What is claimed is a compound represented by the following structural formula: 1 or a pharmaceutically acceptable salt, solvate or clathrate thereof. The variables for Structural Formula (I) are as described herein.

 
Web www.patentalert.com

< Methods of using IL-1 antagonists to treat autoinflammatory disease

< Polypeptide derivatives of parathyroid hormone (PTH)

> Pharmaceutical composition

> Methods for the treatment of synucleinopathies

~ 00225